[Back to Our Trials]
ZWI-ZW25-204: A Phase 1b/2, 2-part Open-label Study to Assess the Safety and Antitumor Activity of Zanidatamab in Combination With ALX148 in Advanced HER2-expressing Cancer
Condition: Breast Cancer
Go To Trial Homepage
For more information you may call clinical trials department directly at 732-390-7750 or email us at
astera.clinicaltrial@asterahealthcare.org
.